Directory
>
Sophia Athanasiou
Sophia Athanasiou
Vice President Patient Safety Risk Management | Relay Therapeutics
United States
Sophia Athanasiou
Summary
Sophia Athanasiou is an accomplished Vice President specializing in Patient Safety and Risk Management within the biopharmaceutical industry. With a strong educational foundation in Pharmacy and Biology from Rutgers University, she has over three decades of experience in drug safety operations and clinical research. Sophia has held significant leadership roles at various organizations, including Relay Therapeutics and Immunomedics, where she has demonstrated her ability to implement global system initiatives and optimize compliance. Her expertise spans across multiple therapeutic areas, particularly in oncology and pharmacovigilance. Known for her strategic thinking and team development skills, she has successfully led cross-functional teams to achieve critical business objectives. Sophia's commitment to patient safety and regulatory compliance has made her a respected figure in her field, and she continues to drive innovation in patient safety practices.
Sophia Athanasiou
Work Experience
Vice President Patient Safety Risk Management at
Relay Therapeutics
July 2024 - Present
Senior Director, Patient Safety & Risk Management at
Relay Therapeutics
July 2021 - July 2024
Director, Safety & Pharmacovigilance at
Immunomedics
September 2020 - July 2021
Head, US Drug Safety at
DBV Technologies
July 2017 - September 2020
Pharmacovigilance Consultant at
Athans Consulting
January 2016 - June 2017
Senior Director, PV Operations at
Acorda Therapeutics, Inc.
January 2013 - January 2016
Director, Pharmacovigilance Operations at
Ferring Pharmaceuticals
September 2010 - January 2013
Associate Director Drug Safety at
ROCHE LEON HOLDINGS
January 1992 - March 2010
Assistant Director, Drug Safety at
Hoffman La Roche
January 1992 - March 2010
Sophia Athanasiou
Education
Rutgers University, Bacholr Of Science
January 1983 - January 1986
Rutgers University - Newark, Bacholor Of Science
January 1980 - January 1983
Frequently Asked Questions about Sophia Athanasiou
What is Sophia Athanasiou email address?
Sophia Athanasiou's primary email address is ***********@relaytx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Sophia Athanasiou work for?
Sophia Athanasiou is a Vice President Patient Safety Risk Management at Relay Therapeutics, a company specializing in Commercial physical research.
Where Sophia Athanasiou graduated from?
Sophia Athanasiou holds a degree in Pharmacy from Rutgers University.
How can I directly contact Sophia Athanasiou?
To contact Sophia Athanasiou directly, you can use the email address ***********@relaytx.com. Complete contact information is available upon registration with Muraena.
Who is Sophia Athanasiou?
Sophia Athanasiou is an accomplished Vice President specializing in Patient Safety and Risk Management within the biopharmaceutical industry. With a strong educational foundation in Pharmacy and Biology from Rutgers University, she has over three decades of experience in drug safety operations and clinical research. Sophia has held significant leadership roles at various organizations, including Relay Therapeutics and Immunomedics, where she has demonstrated her ability to implement global system initiatives and optimize compliance. Her expertise spans across multiple therapeutic areas, particularly in oncology and pharmacovigilance. Known for her strategic thinking and team development skills, she has successfully led cross-functional teams to achieve critical business objectives. Sophia's commitment to patient safety and regulatory compliance has made her a respected figure in her field, and she continues to drive innovation in patient safety practices.
Sophia`s contact details
***********@relaytx.com
***********@acorda.com
Colleagues
Chief Corporate Development Officer
Chief Medical Officer
Senior Vice President, Head of Clinical Development
Vice President - Computational Chemistry
Vice President, Drug Substance Development and Manufacturing (CMC)
Vice President, R&D Portfolio Strategy & Operations
President & CEO
Vice President, Investor Relations & Communications
VP Clinical Science
Vice President, Head of Clinical Operations